May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Topical Mitomycin-C Application Prevents Stromal Haze Formation After Photorefractive Keratectomy
Author Affiliations & Notes
  • M.D. Hirsch
    Dept Ophthalmology, Ophthalmic Consultants of Boston, Boston, MA, United States
  • M.B. Raizman MD
    Dept Ophthalmology, Ophthalmic Consultants of Boston, Boston, MA, United States
  • R.F. Steinert
    Dept Ophthalmology, Ophthalmic Consultants of Boston, Boston, MA, United States
  • Footnotes
    Commercial Relationships  M.D. Hirsch, None; M.B. Raizman MD, None; R.F. Steinert, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2650. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.D. Hirsch, M.B. Raizman MD, R.F. Steinert; Topical Mitomycin-C Application Prevents Stromal Haze Formation After Photorefractive Keratectomy . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2650.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Photorefractive keratectomy can induce the formation of stromal haze. The development of haze appears to increase with the amount of ablation depth. As a result LASIK is often the preferred procedure in patients when large ablation is necessary. However, due to corneal thickness, some patients cannot safely undergo larger ablation treatments because of a lack of adequate residual stromal bed. Our study analyzes the results of patients who underwent PRK because of an inadequate corneal thickness. Topical mitomycin-C was applied intraoperatively to prevent stromal haze formation. The outcomes of these patients are presented. Methods: A retrospective review of all patients who underwent PRK with a one time application of mitomycin-C was undertaken. Patients were included if they had not undergone any other ocular surgical procedure and were not deemed safe candidates for LASIK. Uncorrected and best-spectacle corrected visual acuity was reported preoperatively, at 1month, 3 month, and 6 month's post PRK when available. Accuracy of the procedure was determined by recording the manifest refraction spherical equivalent at 1 month, 3 month, and 6 month post-PRK. Regression to refractive effect was also measured by these results. Post-operative haze observable at the slit-lamp was recorded at 1,3, and 6 months post-PRK. Any complications during the post-operative course were noted and presented Results: 13 patients were identified who met the study critieria. No patient developed haze that decreased best-spectacle corrected visual acuity. No patient developed worse than grade 1 haze based on a scale of 1-4. No patient received an increased topical steroid regimen to treat excessive haze at any point in the follow-up. There was no delay in epithelial healing compared to standard PRK. Most patients were slightly overcorrected at all follow up visits. Conclusions: Photorefractve keratectomy with topical application of mitomycin-C is a safe procedure. No significant haze was noted in any of the patients in the study. Adjustment of a personal nomagram will be needed to improve the refractive results. At a follow up of up to six months topical mitomycin did not cause any adverse outcomes. Longer follow-up will be needed to assure the prevention of late haze development and the long-term refractive results.

Keywords: clinical (human) or epidemiologic studies: pre • cornea: stroma and keratocytes • refractive surgery: PRK 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×